Serum neutrophil gelatinase-associated lipocalin as a predictor of the development of bronchopulmonary dysplasia in preterm infants

Early Human Development

Volumn 89, Issue 6, 2013, Pages 425-429

  Inoue, Hirosuke ^a   Ohga, Shouichi ^a   Kusuda, Takeshi ^a   Kitajima, Junko ^a   Kinjo, Tadamune ^a,b   Ochiai, Masayuki ^a,b   Takahata, Yasushi ^a,b   Honjo, Satoshi ^a,c   Hara, Toshiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c FUKUOKA NATIONAL HOSPITAL   (Japan)

Author keywords

Bronchopulmonary dysplasia; Neutrophil gelatinase associated lipocalin; Preterm infants

Indexed keywords

NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GESTATIONAL AGE; HUMAN; INFANT; LUNG DYSPLASIA; NEUTROPHIL COUNT; PREDICTOR VARIABLE; PREMATURITY; PROTEIN BLOOD LEVEL;

ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; BRONCHOPULMONARY DYSPLASIA; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; LIPOCALINS; NEUTROPHILS; PROTO-ONCOGENE PROTEINS;

EID: 84876696390     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2012.12.011     Document Type: Article

References (24)

1. Kinsella J.P., Greenough A., Abman S.H. Bronchopulmonary dysplasia. Lancet 2006, 367:1421-1431.
2. Hayes D., Feola D.J., Murphy B.S., Shook L.A., Ballard H.O. Pathogenesis of bronchopulmonary dysplasia. Respiration 2010, 79:425-436.
3. Ryan R.M., Ahmed Q., Lakshminrusimha S. Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia. Clin Rev Allergy Immunol 2008, 34:174-190.
4. Davies P.L., Spiller O.B., Beeton M.L., Maxwell N.C., Remold-O'Donnell E., Kotecha S. Relationship of proteinases and proteinase inhibitors with microbial presence in chronic lung disease of prematurity. Thorax 2010, 65:246-251.
5. Kjeldsen L., Johnsen A.H., Sengeløv H., Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993, 268:10425-10432.
6. Xu S., Venge P. Lipocalins as biochemical markers of disease. Biochim Biophys Acta 2000, 1482:298-307.
7. La Manna G., Galletti S., Capelli I., Vandini S., Nisi K., Aquilano G., et al. Urinary neutrophil gelatinase-associated lipocalin at birth predicts early renal function in very low birth weight infants. Pediatr Res 2011, 70:379-383.
8. Tadesse S., Luo G., Park J.S., Kim B.J., Snegovskikh V.V., Zheng T., et al. Intra-amniotic infection upregulates neutrophil gelatinase-associated lipocalin (NGAL) expression at the maternal-fetal interface at term: implications for infection-related preterm birth. Reprod Sci 2011, 18:713-722.
9. Fjaertoft G., Foucard T., Xu S., Venge P. Human neutrophil lipocalin (HNL) as a diagnostic tool in children with acute infections: a study of the kinetics. Acta Paediatr 2005, 94:661-666.
10. Flo T.H., Smith K.D., Sato S., Rodriguez D.J., Holmes M.A., Strong R.K., et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004, 432:917-921.
11. Wu H., Santoni-Rugiu E., Ralfkiaer E., Porse B.T., Moser C., Høiby N., et al. Lipocalin 2 is protective against E. coli pneumonia. Respir Res 2010, 11:96.
12. Chan Y.R., Liu J.S., Pociask D.A., Zheng M., Mietzner T.A., Berger T., et al. Lipocalin 2 is required for pulmonary host defense against Klebsiella infection. J Immunol 2009, 182:4947-4956.
13. Ehrenkranz R.A., Walsh M.C., Vohr B.R., Jobe A.H., Wright L.L., Fanaroff A.A., et al. Validation of the national institutes of health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005, 116:1353-1360.
14. Schmutz N., Henry E., Jopling J., Christensen R.D. Expected ranges for blood neutrophil concentrations of neonates: the Manroe and Mouzinho charts revisited. J Perinatol 2008, 28:275-281.
15. Ishii E., Masuyama T., Yamaguchi H., Saito S., Irie K., Nomiyama M., et al. Production and expression of granulocyte- and macrophage-colony-stimulating factors in newborns: their roles in leukocytosis at birth. Acta Haematol 1995, 94:23-31.
16. Capoluongo E., Vento G., Lulli P., Di Stasio E., Porzio S., Vendettuoli V., et al. Epithelial lining fluid neutrophil-gelatinase-associated lipocalin levels in premature newborns with bronchopulmonary dysplasia and patency of ductus arteriosus. Int J Immunopathol Pharmacol 2008, 21:173-179.
17. Wagenaar G.T., ter Horst S.A., van Gastelen M.A., Leijser L.M., Mauad T., van der Velden P.A., et al. Gene expression profile and histopathology of experimental bronchopulmonary dysplasia induced by prolonged oxidative stress. Free Radic Biol Med 2004, 36:782-801.
18. Dik W.A., van Kaam A.H., Dekker T., Naber B.A., Janssen D.J., Kroon A.A., et al. Early increased levels of matrix metalloproteinase-9 in neonates recovering from respiratory distress syndrome. Biol Neonate 2006, 89:6-14.
19. Sveger T., Ohlsson K., Polberger S., Noack G., Mörse H., Laurin S. Tracheobronchial aspirate fluid neutrophil lipocalin, elastase- and neutrophil protease-4-alpha1-antitrypsin complexes, protease inhibitors and free proteolytic activity in respiratory distress syndrome. Acta Paediatr 2002, 91:934-937.
20. Sveger T., Ohlsson K., Mörse H., Polberger S., Laurin S. Plasma neutrophil lipocalin, elastase-alpha1-antitrypsin complex and neutrophil protease 4 in preterm infants with respiratory distress syndrome. Scand J Clin Lab Invest 2003, 63:89-92.
21. Miharada K., Hiroyama T., Sudo K., Danjo I., Nagasawa T., Nakamura Y. Lipocalin 2-mediated growth suppression is evident in human erythroid and monocyte/macrophage lineage cells. J Cell Physiol 2008, 215:526-537.
22. Ekekezie I.I., Thibeault D.W., Simon S.D., Norberg M., Merrill J.D., Ballard R.A., et al. Low levels of tissue inhibitors of metalloproteinases with a high matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio are present in tracheal aspirate fluids of infants who develop chronic lung disease. Pediatrics 2004, 113:1709-1714.
23. Tambunting F., Beharry K.D., Hartleroad J., Waltzman J., Stavitsky Y., Modanlou H.D. Increased lung matrix metalloproteinase-9 levels in extremely premature baboons with bronchopulmonary dysplasia. Pediatr Pulmonol 2005, 39:5-14.
24. Yan L., Borregaard N., Kjeldsen L., Moses M.A. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 2001, 276:37258-37265.